Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Epidermal stem cells are vital for skin healing and have potential for treating skin disorders.

Women with Frontal Fibrosing Alopecia have more wrinkles near their ears than similar aged women without the condition.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Erdr1 could be a new marker for diagnosing hair loss.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

EpiLife® media and younger donor age improve artificial skin model quality.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

The study found that a specific signaling pathway helps skin wounds heal faster but may lead to larger scars.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Early and accurate diagnosis of posterior scalp hair loss is crucial for effective treatment and better outcomes.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

Early and accurate identification of primary scarring alopecias is crucial to prevent permanent hair loss.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.